Projekt

A Study to Evaluate Imetelstat (GRN163L) in Transfu-sion-Dependent Subjects with IPSS Low or Intermedi-ate-1 Risk Myelodysplastic Syndrome (MDS) that is Re-lapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Laufend - Rekrutierung – beendet · 2021 bis 2030

Silzle Tobias, Driessen Christoph, Fehr Martin, Hitz Felicitas, Lehmann Thomas